Ct-based radiomics can predict the efficacy of anlotinib in advanced non-small-cell lung cancer

HIGHLIGHTS

  • who: Jingyu Chen et al. from the Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China have published the research work: CT-Based Radiomics Can Predict the Efficacy of Anlotinib in Advanced Non-Small-Cell Lung Cancer, in the Journal: Journal of Oncology of 26/Dec/2022
  • what: In this study, complete treatment history and follow-up data were collected from 362 patients, and after censoring 38 patients who were unable to obtain baseline CT, 28 patients who lacked intrapulmonary lesions, and 14 patients who did not . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?